Sharps Compliance to Participate in the Oppenheimer 5th Annual Emerging Growth Conference
Sharps Compliance Corp. (Nasdaq: SMED) announced that CEO David P. Tusa will speak at Oppenheimer’s 5th Annual Emerging Growth Conference on May 12, 2020. This virtual event allows Mr. Tusa to engage in one-on-one and small group meetings throughout the day.
Based in Houston, Sharps Compliance is a leading provider of waste management services, including medical, pharmaceutical, and hazardous waste. Their flagship product, the Sharps Recovery System, offers comprehensive solutions for medical waste management across various healthcare sectors.
- None.
- None.
Insights
Analyzing...
HOUSTON, May 05, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, Chief Executive Officer has been invited to participate in Oppenheimer’s 5th Annual Emerging Growth Conference, which will take place virtually on Tuesday, May 12, 2020. Mr. Tusa will be available throughout the day for one-on-one and small group meetings via teleconference.
About Sharps Compliance Corp.
Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous. Its key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living / long-term care, surgery centers, retail pharmacies and clinics, and the professional market which is comprised of physicians, dentists and veterinary practices. The Company's flagship product, the Sharps Recovery System, is a comprehensive solution for the containment, transportation, treatment and tracking of medical waste and other used healthcare materials. The Company also offers its route-based pick-up service in a thirty-two (32) state region of the South, Southeast and Northeast portions of the United States. Sharps also provides two simple solutions for safe and easy disposal of unused medications: MedSafe collection receptacles and TakeAway Medication Recovery System Envelopes.
More information on the Company and its products can be found on its website at: www.sharpsinc.com
10%; width: | 90%; width: |
8%; width: | 92%; width: Email: ddiaz@sharpsinc.com Office: (713) 660-3547 |
8%; width: | 92%; width: |
Investor Contact: | John Nesbett/Jennifer Belodeau |
Institutional Marketing Services Email: jnesbett@institutionalms.com Office: (203) 972-9200 |